Asit Parikh, MOMA Therapeutics CEO
January 4, 2024 07:00 AM EST
Startups
Deals
Pharma

Roche pens third pact of the week in $66M up­front to MO­MA Ther­a­peu­tics

Kyle LaHucik

Senior Reporter

Roche is off to the races in 2024, with the Swiss Big Phar­ma ink­ing its third biotech col­lab­o­ra­tion this year on Thurs­day morn­ing.

As part …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

The End­points 2024 win­ners and losers list: Who was up and who was down in bio­phar­ma

Ca­griSe­ma’s weight loss da­ta dis­ap­point­ed. What does No­vo do next?

Ex­clu­sive: Flori­da can­cer biotech rais­es $100M Se­ries A

FDA ap­proves Lil­ly's Zep­bound for sleep ap­nea, like­ly crack­ing open Medicare mar­ket

CMS ex­plains what went in­to its first round of drug price ne­go­ti­a­tions

Ver­tex gets 'van­za triple' ap­proval and Trikaf­ta ex­pan­sion — with boxed warn­ings

A service from the Financial Times